<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><!-- InstanceBegin template="/Templates/ContentPage_Standard.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<!-- InstanceParam name="id" type="text" value="undefined" --><!-- InstanceParam name="class" type="text" value="secondTier" --><!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="optionSpanish" type="boolean" value="false" --><!-- InstanceParam name="optionalFeatures" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" --><!-- InstanceParam name="optionalExtra" type="boolean" value="false" --><!-- InstanceParam name="JqueryUI" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiAccordion" type="boolean" value="false" --><!-- InstanceParam name="dojoLibrary" type="boolean" value="false" -->
<meta http-equiv="content-type" content="text/html; charset=utf-8" />
<!-- InstanceBeginEditable name="meta-data" -->
<meta name="Keywords" 		content="HICPAC, infection prevention and control guidelines and recommendation, Updating the Guideline Methodology, Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings, Guideline for the Prevention of Intravascular Catheter-Related Bloodstream Infections, BSI guidelines, Norovirus guidelines, Guideline for Prevention of Catheter-associated Urinary Tract Infections, UTI guidelines, Guideline for Disinfection and Sterilization in Healthcare Facilities, Disinfection and Sterilization Guidelines, Guideline for Isolation Precautions, Guideline for Hand Hygiene in Healthcare Settings, Guidance on Public Reporting of HAIs, Guideline for Preventing Healthcare-Associated Pneumonia, Guideline for the Prevention of Surgical Site Infection, SSI Guidelines, Management of Multidrug-Resistant Organisms In Healthcare Settings, MDRO, Guidance for Control of Infections with Carbapenem-Resistant or Carbapenemase-Producing Enterobacteriaceae in Acute Care Facilities, Guideline for Infection Control in Hospital Personnel,  Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program, Immunization of Health-Care Workers: Recommendations of ACIP and HICPAC, HICPAC current roster, healthcare, health departments, healthcare providers, antimicrobial, antibiotic-resistant, pathogens, Coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus species, Candida species, Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter species, Acinetobacter baumannii, Klebsiella oxytoca, multidrug-resistant, Methicillin-resistant Staphylococcus aureus, Vancomycin-resistant Enterococci (VRE) faecium, Carbapenem-resistant P. aeruginosa, Extended-spectrum cephalosporin-resistant K. pneumoniae, Carbapenem-resistant A. baumannii, VISA/VERS, Acinetobacter, Burkholderia cepacia, Clostridium sordellii, CDAD, CDI, Enterobacteriaceae (Carbapenem-resistance),Hepatitis, Klebsiella, MRSA, Mycobacterium abscessus, Norovirus, Staphylococcus aureus, Tuberculosis (TB),Vancomycin-intermediate Staphylococcus aureus, Vancomycin-resistant Staphylococcus aureus, Surgical Site Infection (SSI), Ventilator-associated Pneumonia (VAP), Ambulatory Settings, Ambulatory surgical centers, Dialysis Setting, Long-term care facilities (LTCFs), LTC " />
<meta name="DC.Subject" 	content="" />
<meta name="DC.Language" 	scheme="ISO 639-2" content="eng" />



<!-- InstanceEndEditable -->
<meta name="template.version" content="2.5.2" />
<!-- @package: TemplatePackage 'B' @version: "2.5.2" -->
<!-- InstanceBeginEditable name="title-tag" -->
<title>CDC - 2010 Norovirus Guidelines: Summary of Recommendations - HICPAC</title>




<!-- InstanceEndEditable -->
<style type="text/css" media="tv">
empty{color:#000};@import "../../TemplatePackage/css/B/wysiwyg/wysiBaseHome.css"/**/;
</style>
<style type="text/css" media="screen, projection">
@import "../../TemplatePackage/css/B/base-float.css"/**/;
</style>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/share.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/external.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/plugins.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/socialMedia.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->
<style type="text/css" media="print">@import "../../TemplatePackage/css/B/print.css";</style>

<link rel="shortcut icon" href="../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->


<!-- Local Topic Styles -->
<!-- InstanceBeginEditable name="local-css" -->
<style type="text/css" media="all">
@import "../local/B/css/local.css"/**/;
</style>
<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		
		var cdcLeftNav = new CDC.LeftNav("nav-primary", location.pathname, true, true);
		cdcLeftNav.render();

});
</script>
<!--<![endif]-->




<!-- InstanceEndEditable -->
</head>
<body id="undefined" class="secondTier">

<div id="skipmenu">
	<a href="005_norovirus-summaryOrecs.html#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="005_norovirus-summaryOrecs.html#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="005_norovirus-summaryOrecs.html#nav" class="skippy" title="Skip to navigation">Skip directly to navigation</a>
	<a href="005_norovirus-summaryOrecs.html#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
	<a href="005_norovirus-summaryOrecs.html#content-secondary" class="skippy" title="Skip to page options">Skip directly to page options</a>
</div>
<div id="wrapper">
	<div class="top"></div>
	<div id="wrapper-inner">
		<div id="branding">
			<span id="homeward"><a href="../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC 24/7: Saving Lives. Protecting People.&trade;" border="0" /><a href="../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>
	<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
</div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
			<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
			<h2><a href="../index.html">Healthcare Infection Control Practices Advisory Committee (HICPAC)</a></h2>
			<!-- InstanceEndEditable -->
			</div>
		</div>
		
		<div id="content">
			<div id="content-inner">
				
				<!-- ########## LEFT NAVIGATION STARTS HERE ########## -->
				<div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" --> <div id="nav">
  <h3><a href="../index.html">HICPAC</a></h3>
	<ul id="nav-primary">
    <li><a href="../about.html">About HICPAC</a></li>
    <li><a href="../roster.html">Member Roster</a></li>
    <li><a href="../charter.html">Charter</a> </li>
    <li><a href="../eCalendar.html">Event Calendar</a>
      <!--ul>
        <li><a href="/hicpac/agenda.html">Meeting Agenda</a></li>  
      </ul-->
    </li>
    <li><a href="../guidelineMethod/guidelineMethod.html">Methodology Guideline</a>
      <ul>
        <li><a href="../guidelineMethod/001_methods_background.html">Background</a></li>
        <li><a href="../guidelineMethod/002_methods_emergingNeeds.html">Strengthening HICPAC Guidelines to Address Emerging Needs</a></li>
        <li><a href="../guidelineMethod/003_methods_Organiz2AccomplishGoals.html">Organizing to Accomplish Our Goals</a> </li>
        <li><a href="../guidelineMethod/004_methods_guidelineDevelopment.html">Methods in Guideline Development</a></li>
        <li><a href="../guidelineMethod/005_methods_challengesOpportunities.html">Looking to Future Challenges and Opportunities</a></li>
        <li><a href="../guidelineMethod/007_methods_References.html">References</a></li>
        <li><a href="../guidelineMethod/008_methods_tables.html">Tables</a></li>
        <li><a href="../guidelineMethod/011_methods_figures.html">Figures</a></li>
      </ul>
    </li>
	<!--li><a href="/hicpac/projects_in_progress.html">Projects in Progress</a></li-->
	<li><a href="../pubs.html">Publications</a>
			<ul>
			  <li><a href="../BSI/BSI-guidelines-2011.html">2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections</a>
		        <ul>
		          <li><a href="../BSI/toc-BSI-guidelines-2011.html">Table of Contents</a></li>
		          <li><a href="../BSI/01-BSI-guidelines-2011.html">Notice to Readers</a> </li>
		          <li><a href="../BSI/02-bsi-summary-of-recommendations-2011.html">Summary Of Recommendations</a> </li>
		          <li><a href="../BSI/03-bsi-summary-of-recommendations-2011.html">Patient Cleansing 
		            </a></li>
		          <li><a href="../BSI/04-bsi-background-info-2011.html">Background Information</a></li>
		          <li><a href="../BSI/05-bsi-background-info-2011.html">Maximal Sterile Barrier Precautions 
		            </a></li>
		          <li><a href="../BSI/06-bsi-background-info-2011.html">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis 
		            </a></li>
		          <li><a href="../BSI/07-bsi-background-info-2011.htmles-2011.html">Replacement of Administration Sets</a></li>
		          <li><a href="../BSI/bsi-table-1-2011.html">Table 1. Catheters used for venous and arterial access</a></li>
		          <li><a href="../BSI/13-references-BSI-guidelines-2011.html">References</a></li>
		          <li><a href="../BSI/11-appendix-B-BSI-guidelines-2011.html">Appendix B. Disclosure of financial interests or relationships</a></li>
		          <li><a href="../BSI/12-appendix-C-BSI-guidelines-2011.html">Appendix C. Summary of Recommendations</a></li>
	            </ul>
			  </li>
		      <li><a href="002_norovirus-toc.html">2011 Norovirus Guidelines
		        </a>
		        <ul>
		          <li><a href="003_norovirus-abbreviations.html">Abbreviations</a></li>
					   
					   <li><a href="001_norovirus.html">Acknowledgement</a></li>
					   <li><a href="004_norovirus-exec-summary.html">Executive Summary</a></li>
					   <li><a href="005_norovirus-summaryOrecs.html">Summary of Recommendations</a></li>
					   <li><a href="006_norovirus-implement-audit.html">Implementation and Audit</a> </li>
					   <li> <a href="007_norovirus-recs-further-research.html">Recommendations for Further Research					     </a></li>
					   <li><a href="008_norovirus-background.html">Background					     </a></li>
					   <li><a href="009_norovirus-scope.html">Scope and Purpose</a> </li>
					   <li><a href="010_norovirus-methods.html">Methods</a> </li>
					   <li><a href="011_norovirus-evidence-review.html">Evidence Review Question 1</a>				       </li>
                       <li><a href="012_norovirus-evidence-q2.html">Question 2</a></li>
                       <li><a href="013_norovirus-evidence-q3.html">Question 3</a></li>
                  <li><a href="norovirus-appendix-1.html">Appendix 1</a></li>
                       <li><a href="norovirus-appendix-1b.html">Appendix 1B</a> </li>
                       <li><a href="tables/evidence-Table1.html">Evidence, Grade &amp; Study Quality Assessment Tables</a></li>
                  <li><a href="norovirus-appendix-3.html">Appendix 3</a></li>
                       <li><a href="norovirus-appendix-4.html">Appendix 4</a></li>
                       <li><a href="norovirus-references.html">References</a></li>
		        </ul>
		      </li>
	          <li><a href="../Disinfection_Sterilization/acknowledg.html">2008 Disinfection &amp; Sterilization Guideline</a>               
	            <ul>
	              <li><a href="../Disinfection_Sterilization/toc.html">Table of Contents</a></li>
	              <li><a href="../Disinfection_Sterilization/1_sumIntroMethTerms.html">Executive Summary</a> </li>
	              <li><a href="../Disinfection_Sterilization/2_approach.html">Approach to Disinfection and Sterilization</a> 
	                  <ul>
	                    <li><a href="../Disinfection_Sterilization/3_0disinfectEquipment.html">Disinfection of Healthcare Equipment</a></li>
                        <li><a href="../Disinfection_Sterilization/3_1deLaparoArthro.html">Laparoscopes and Arthroscopes</a> </li>
                        <li><a href="../Disinfection_Sterilization/3_2contaminatedDevices.html">Disinfection of HBV, HCV, HIV or TB-Contaminated Devices</a></li>
                        <li><a href="../Disinfection_Sterilization/3_3inactivBioAgents.html">Inactivation of Bioterrorist Agents</a></li>
                        <li><a href="../Disinfection_Sterilization/3_4surfaceDisinfection.html">Surface Disinfection</a></li>
                    </ul>
	              </li>
                  <li><a href="../Disinfection_Sterilization/4_0efficacyDS.html">Factors Affecting The Efficacy Of Disinfection And Sterilization</a></li>
                  <li><a href="../Disinfection_Sterilization/5_0cleaning.html">Cleaning</a></li>
                  <li><a href="../Disinfection_Sterilization/6_0disinfection.html">Disinfection</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/7_0formaldehyde.html">Formaldehyde</a></li>
                      <li><a href="../Disinfection_Sterilization/8_0Iodophors.html">Iodophors</a></li>
                      <li><a href="../Disinfection_Sterilization/9_0PceticAcidHydroPoxide.html">Peracetic Acid and Hydrogen Peroxide</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/10_0MiscAgents.html">Miscellaneous Inactivating Agents</a></li>
                  <li><a href="../Disinfection_Sterilization/11_0regulatory_Framework.html">Regulatory Framework for Disinfectants and Sterilants</a></li>
                  <li><a href="../Disinfection_Sterilization/13_0Sterilization.html">Sterilization</a>
                      <ul>
	                      
                        <li><a href="../Disinfection_Sterilization/13_02sterilization.html">Low-Temperature Sterilization Technologies</a></li>
		                          
                        <li><a href="../Disinfection_Sterilization/13_06PeraceticAcidSterilization.html">Peracetic Acid Sterilization</a></li>
		                         
                        <li><a href="../Disinfection_Sterilization/13_10otherSterilizationMethods.html">Other Sterilization Methods</a></li>
                        <li><a href="../Disinfection_Sterilization/13_11sterilizingPractices.html">Sterilizing Practices</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/14_00ReuseMedicalDevices.html">Reuse of Single-Use Medical Devices</a></li>
                  <li><a href="../Disinfection_Sterilization/17_00Recommendations.html">Recommendations for Disinfection and Sterilization in Health-Care Facilities</a></li>
                  <li><a href="../Disinfection_Sterilization/18_00PerformanceIndicators.html">Performance Indicators</a></li>
                  <li><a href="../Disinfection_Sterilization/19_00glossary.html">Glossary</a></li>
                  <li><a href="../Disinfection_Sterilization/table_1.html">Tables &amp; Figure</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/table_2.html">Table 2, 3</a></li>
                      <li><a href="../Disinfection_Sterilization/fig_1.html">Figure 1</a></li>
                      <li><a href="../Disinfection_Sterilization/table_4.html">Table 4</a></li>
                      <li><a href="../Disinfection_Sterilization/table_5.html">Table 5</a></li>
                      <li><a href="../Disinfection_Sterilization/table_6.html">Table 6</a></li>
                      <li><a href="../Disinfection_Sterilization/table_7.html">Table 7, 8, 9</a></li>
                      <li><a href="../Disinfection_Sterilization/table_10.html">Table 10, 11, 12</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/20_00reference.html">References</a></li>
                </ul>
              </li>
	          <li><a href="../2007IP/2007isolationPrecautions.html">Guideline for Isolation Precautions 2007</a>
				  <ul>
                        <li><a href="../2007IP/2007ip_ExecSummary.html">Executive Summary</a></li>
                        <li> <a href="../2007IP/2007ip_part1.html">Part I: Review of Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings</a></li>
                        <li><a href="../2007IP/2007ip_part2.html">Part II: Fundamental elements needed to prevent transmission of infectious agents in healthcare settings</a></li>
                        <li><a href="../2007IP/2007ip_part3.html">Part III: Precautions to Prevent Transmission of Infectious Agents</a></li>
                        <li><a href="../2007IP/2007ip_part4.html">Part IV: Recommendations</a></li>
                        <li><a href="../2007IP/2007ip_appendA.html">Appendix A</a></li>
                        <li><a href="../2007IP/2007ip_tables.html">Tables 1 - 5</a>
                          <ul>
                            <li><a href="../2007IP/2007ip_table2.html">Table 2</a></li>
                            <li><a href="../2007IP/2007ip_table3.html">Table 3</a></li>
                            <li><a href="../2007IP/2007ip_table4.html">Table 4</a></li>
                            <li><a href="../2007IP/2007ip_table5.html">Table 5</a></li>
                          </ul>
                        </li>
                        <li><a href="../2007IP/2007ip_fig.html">Figure. Example of Safe Donning and Removal of PPE</a></li>
                        <li><a href="../2007IP/2007ip_glossary.html">Glossary</a></li>
                        <li><a href="../2007IP/2007ip_reference.html">References</a></li>
                </ul>
			  </li>
			    
	            <li><a href="../cauti/001_cauti.html">2009 CAUTI Guideline</a>
	              <ul>
	                <li><a href="../cauti/002_cauti_toc.html">Table of Contents</a>
	                  <!--<ul><li><a href="/hicpac/Disinfection_Sterilization/1_sumIntroMethTerms-levi.html">test</a></li></ul>-->
                    </li>
                      <li><a href="../cauti/02_cauti2009_abbrev.html">Abbreviations</a></li>
                      <li><a href="../cauti/003_cauti2009_execSum.html">I. Executive Summary</a></li>
                      <li><a href="../cauti/002_cauti_sumORecom.html">II. Summary of Recommendations</a></li>
                      <li><a href="../cauti/003_ImplementAudit.html">III. Implementation and Audit</a></li>
                      <li><a href="../cauti/004_furtherResearch.html">IV. Recommendations for Further Research</a></li>
                      <li><a href="../cauti/005_background.html">V. Background</a></li>
                      <li><a href="../cauti/006_scopePurpose.html">VI. Scope and Purpose</a></li>
                      <li><a href="../cauti/007_methods.html">VII. Methods</a></li>
                      <li><a href="../cauti/008_evidenceReview.html">VIII. Evidence Review</a></li>
                      <li><a href="../cauti/009_cauti2009_References.html">References</a></li>
                      <li><a href="../cauti/010_cauti2009_figs.html">Figures</a></li>
		          </ul>
              </li>
              
              <li><a href="../CAUTI_fastFacts.html">CAUTI Guideline Fast Facts</a></li>
              <li><a href="../uti_saint_video.html">Podcast: Dr. Sanjay Saint discusses CAUTIs</a></li>
              <li><a href="../mdro/mdro_0.html">Management of MDRO's in Healthcare Settings</a>
	          <ul>
	            <li><a href="../mdro/mdro_toc.html">Table of Contents</a></li>
	            <li><a href="../mdro/mdro_1.html">Introduction</a></li>
	            <li><a href="../mdro/mdro_2.html">Background</a></li>
	            <li><a href="../mdro/mdro_3.html">Epidemiology of MDROs</a></li>
	            <li><a href="../mdro/mdro_4.html">MDRO Prevention and Control</a></li>
	            <li><a href="../mdro/mdro_4_1.html">Discussion</a></li>
	            <li><a href="../mdro/mdro_5.html">Prevention of transmission of Multidrug Resistant Organisms </a></li>
	            <li><a href="../mdro/mdro_table1.html">Tables 1-2</a></li>
	            <li><a href="../mdro/mdro_table3.html">Table 3</a> </li>
	            <li><a href="../mdro/mdro_glossary.html">Glossary - Multidrug-Resistant Organisms</a></li>
	            <li><a href="../mdro/mdro_reference.html">References</a></li>
              </ul>
	        </li>
	        <li><a href="../pubReportGuide/publicReportingHAI.html">Guidance on Public Reporting of HAIs 2003</a>
			      <ul>
			        <li><a href="../pubReportGuide/prg_tbl1.html">Table 1</a></li>
		            <li><a href="../pubReportGuide/prg_tbl2.html">Table 2</a></li>
                    <li><a href="../pubReportGuide/prHAI_reference.html">Reference</a></li>
	              </ul>
		      </li>
            <li><a href="../SSI/001_SSI.html">Guideline for Prevention of Surgical Site Infection, 1999 </a>
              <ul>
                <li><a href="../SSI/toc_SSI.html"> Table of contents</a></li>
                
                <li><a href="../SSI/002_SSI.html">Surgical Site Infection (SSI): An Overview</a></li>
                <li><a href="../SSI/003_SSI.html">Microbiology</a></li>
                <li><a href="../SSI/004_SSI.html"> Operative characteristics: Preoperative issues                                 </a></li>
                <li><a href="../SSI/005_SSI.html">Operative characteristics: Intraoperative issues 
                                 </a></li>
                <li><a href="../SSI/006_SSI.html">SSI Surveillance </a></li>
                <li><a href="../SSI/007_SSI.html">Recommendations for Prevention of SSI</a></li>
                <li><a href="../SSI/ref-SSI.html">References </a></li>
                <li><a href="../SSI/figure-SSI.html">Figure</a></li>
                <li><a href="../SSI/table1-SSI.html">Table 1</a></li>
                <li><a href="../SSI/table2-SSI.html">Table 2</a></li>
                <li><a href="../SSI/table3-SSI.html">Table 3</a></li>
                <li><a href="../SSI/table4-SSI.html">Table 4</a></li>
                <li><a href="../SSI/table5-SSI.html">Table 5</a></li>
                <li><a href="../SSI/table6-SSI.html">Table 6</a></li>
                <li><a href="../SSI/table7-8-9-10-SSI.html">Table 7-8-9-10</a></li>
              </ul>
            </li>
            <li><a href="../Pubs/Antibiotic-Stewardship-Statement.html">Antibiotic Stewardship Statement for Antibiotic Guidelines, 2016</a></li>
      </ul>
	  </li>
       
	<li><a href="../presentations.html">Proceedings &amp; Presentations</a>
	  <!--ul>
	    <li><a href="/hicpac/transcript-07-23.html">July 09 - Interim Guidance for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
        <li><a href="/hicpac/h1n12009.html">Summary of Recommendations for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
	  </ul-->
	</li>
   
    <!--li><a href="/hicpac/registration.html">HICPAC Online Registration</a></li-->
    <li><a href="../contact.html">Contact HICPAC</a></li>
  </ul>
</div>
<div class="bottom"></div>

				
				<!-- InstanceEndEditable -->
				</div>
				
				<!-- ########## BREADCRUMBS START HERE ########## -->
				<!-- InstanceBeginEditable name="breadcrumbs" -->
			<div id="breadBox">
	<ul id="breadcrumbs">
		<li style="display:none;"></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
				<div id="content-main">
					<div class="main-inner">
						
						<!-- InstanceBeginEditable name="content-main" -->
                                               
					 <h1>Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings, 2011</h1>

<div class="module double-rule">
<div class="inner">
<div class="subColumns">
<div class="subc">
                    <p class="lastChild">Download the complete PDF version <a href="https://www.cdc.gov/hicpac/pdf/norovirus/Norovirus-Guideline-2011.pdf" >Guideline for the Prevention and Control of Norovirus Gastroenteritis Outbreaks in Healthcare Settings, 2011 [PDF - 676 KB]</a> and <a href="https://www.cdc.gov/hicpac/pdf/norovirus/Norovirus-Guideline-appendices-2011.pdf">Appendices [PDF - 3.48 MB]</a>.     </p>
                     
                     </div>
</div>
</div>
</div>
                     
                     <div id="onthispage">
<div class="rounders grey bulleted-links">
<div class="inner">
<div class="t"></div>

<h4>On this Page</h4>
<div class="subc">
<ul>
<li><a href="005_norovirus-summaryOrecs.html#tbl1">Table 1. HICPAC Categorization Scheme for  Recommendations</a></li>
<li><a href="005_norovirus-summaryOrecs.html#pcip">Patient Cohorting and Isolation Precautions</a></li>
<li><a href="005_norovirus-summaryOrecs.html#hh">Hand Hygiene</a></li>
<li><a href="005_norovirus-summaryOrecs.html#ptwc">Patient Transfer and Ward Closure </a></li>
<li><a href="005_norovirus-summaryOrecs.html#diag">Diagnostics </a></li>
<li><a href="005_norovirus-summaryOrecs.html#ppe">Personal Protective Equipment </a></li>
<li><a href="005_norovirus-summaryOrecs.html#ec">Environmental Cleaning </a></li>
<li><a href="005_norovirus-summaryOrecs.html#slp">Staff Leave and Policy</a></li>
<li><a href="005_norovirus-summaryOrecs.html#visit">Visitors</a></li>
<li><a href="005_norovirus-summaryOrecs.html#edu">Education</a></li>
<li><a href="005_norovirus-summaryOrecs.html#acf">Active Case-Finding </a></li>
<li><a href="005_norovirus-summaryOrecs.html#cn">Communication and Notification</a></li>
</ul>

</div>
</div>

<div class="b">
<div></div>
</div>
</div>
</div>

                     
                    
					<div class="subColumns">
                    
                     
                      
                        
                       
                       
                      
                      
                   
 <h2>II. Summary of Recommendations</h2>

                      <table width="95%" border="0" cellspacing="1" cellpadding="1">
                        <tr id="tbl1">
                          <th colspan="2" scope="col"><strong>Table 1. HICPAC Categorization Scheme for  Recommendations</strong></th>
                        </tr>
                        <tr id="cia">
                          <td>Category IA</td>
                          <td>A strong recommendation supported by high to  moderate quality evidence suggesting net clinical benefits or harms.</td>
                        </tr>
                        <tr id="cib">
                          <td>Category IB</td>
                          <td>A strong recommendation supported by low-quality  evidence suggesting net clinical benefits or harms, or an accepted practice  (e.g., aseptic technique) supported by low to very low-quality evidence.</td>
                        </tr>
                        <tr id="cic">
                          <td>Category IC</td>
                          <td>A strong recommendation required by state or  federal regulation.</td>
                        </tr>
                        <tr id="cii">
                          <td>Category II</td>
                          <td>A weak recommendation supported by any quality  evidence suggesting a tradeoff between clinical benefits and harms.</td>
                        </tr>
                        <tr id="rfr">
                          <td>Recommendation for further research</td>
                          <td>An unresolved issue for which there is low to  very low-quality evidence with uncertain tradeoffs between benefits and harms.</td>
                        </tr>
                      </table>
                      
                       </div>
                      <p>*Please refer to Methods Section and Umscheid et al. <a href="../guidelineMethod/guidelineMethod.html">Updating the Guideline Methodology of the Healthcare Infection Control Practices Advisory Committee (HICPAC) </a> for the process used to grade quality of evidence and implications of category designation 
                      
                        <br />
                        **Key questions are described within the Evidence Review Section</p>
                       
                        
                        
                        <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                        
                      <h3 id="pcip">Patient Cohorting And Isolation Precautions</h3>
                      <ol>
                        <li>Avoid  exposure to vomitus or diarrhea.  Place patients  on Contact Precautions in a single occupancy room if they have symptoms  consistent with norovirus gastroenteritis.   <strong>(Category IB)</strong>(Key Question 1.A.1)
                            <ol>
                              <li>When patients with norovirus  gastroenteritis cannot be accommodated in single occupancy rooms, efforts  should be made to separate them from asymptomatic patients. Dependent upon  facility characteristics, approaches for cohorting patients during outbreaks  may include placing patients in multi-occupancy rooms, or designating patient  care areas or contiguous sections within a facility for patient cohorts. <strong>(Category IB)</strong> (Key Question 3C.4.b)</li>
                            </ol>
                        </li>
                       
                        <li>During  outbreaks, place patients with norovirus gastroenteritis on Contact Precautions  for a minimum of 48 hours after the resolution of symptoms to prevent further  exposure of susceptible patients <strong>(Category IB)</strong> (Key Question 3.C.4.a) 
                            <ol>
                              <li>Consider longer periods of isolation  or cohorting precautions for complex medical patients (e.g., those with cardiovascular,  autoimmune, immunosuppressive, or renal disorders)  as they can experience protracted episodes of  diarrhea<strong> </strong>and prolonged viral  shedding.  Patients with these or other  comorbidities have the potential to relapse, and facilities may choose longer  periods of isolation based on clinical judgment.<strong>(Category II)</strong>  (Key Question 1.A.2.a) </li>
                              
                            <li>Consider extending the duration of  isolation or cohorting precautions for outbreaks among infants and young  children (e.g., under 2 years), even after resolution of symptoms, as there is  a potential for prolonged viral shedding and environmental contamination. Among  infants, there is evidence to consider extending contact precautions for up to  5 days after the resolution of symptoms.<strong>(Category II)</strong>  (Key Question 3.A.1)</li>
                            </ol>
                        </li>
                       
                          
                        
                        <li>Further  research is needed to understand the correlation between prolonged shedding of  norovirus and the risk of infection to susceptible patients<strong> (No recommendation/unresolved issue) </strong>(Key Question 3.A.2)</li>
                      
                        <li>Consider  minimizing patient movements within a ward or unit during norovirus  gastroenteritis outbreaks.<strong>(Category II)</strong>  (Key Question 3.C.4.c)   
                        
                            <ol>
                              <li>Consider restricting symptomatic and  recovering patients from leaving the patient-care area unless it is for  essential care or treatment to reduce the likelihood of environmental  contamination and transmission of norovirus in unaffected clinical areas. <strong>(Category II)</strong>  (Key Question 3.C.4.c.1) </li>
                            </ol>
                        </li>
                        
                        <li>Consider  suspending group activities (e.g., dining events) for the duration of a  norovirus outbreak. <strong>(Category II)</strong>  (Key Question 3.C.4.d)      </li>
                      
                        <li>Staff  who have recovered from recent suspected norovirus infection associated with an  outbreak may be best suited to care for symptomatic patients until the outbreak  resolves.<strong>(Category II)</strong> (Key Question  3.C.5.b) </li>
                        </ol>
                        <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                        
                        <h3 id="hh">Hand Hygiene                        </h3>
                        <ol start="7">
                      
                        <li value="7">Actively  promote adherence to hand hygiene among healthcare personnel, patients, and  visitors in patient care areas affected by outbreaks of norovirus  gastroenteritis. <strong>(Category&nbsp;IB)</strong>(Key  Question 3.C.1.a)</li>
                     
                        <li>During  outbreaks, use soap and water for hand hygiene after providing care or having  contact with patients suspected or confirmed with norovirus gastroenteritis. <strong>(Category IB)</strong>(Key Question 3.C.1.b)
                        
                            <ol>
                              <li>For all other hand hygiene indications  (e.g., before having contact with norovirus patients) refer to the <a href="https://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf">2002 HICPAC  Guideline for Hand Hygiene in Health-Care Settings</a>, which includes the indications for  use of FDA-compliant alcohol-based hand sanitizer. <strong>(Category IB)</strong>(Key Question 3.C.1.b.1)
                              
                                <ol type="1">
                                  <li type="1">Consider ethanol-based hand sanitizers (60-95%)  as the preferred active agent compared to other alcohol or non-alcohol based  hand sanitizer products during outbreaks of norovirus gastroenteritis. <strong>(Category II)</strong>  (Key Question 3.C.1.b.2)</li>
                                </ol>
                              </li>
                      <li>Further research  is required to directly evaluate the efficacy of alcohol-based hand sanitizers  against human strains of norovirus, or against a surrogate virus with  properties convergent with human strains of norovirus. <strong>(No recommendation/unresolved issue)</strong> (Key Question 3.C.1.b.3)                          </li>
                            </ol>
                          </li>
                          
                         
                          <li>More  research is required to evaluate the virucidal capabilities of alcohol-based as  well as non-alcohol based hand sanitizers against norovirus.   <strong>(No  recommendation/unresolved issue) </strong>(Key Question 3.C.12.e.4)  </li>
                        </ol>
                        
                        <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                        
                          <h3 id="ptwc">Patient Transfer and Ward Closure                          </h3>
                        <ol start="10">
                          
                           <li value="10">Consider the closure of wards to new  admissions or transfers as a measure to attenuate the magnitude of an outbreak  of norovirus gastroenteritis.  The threshold  for ward closure varies and depends on risk assessments by infection prevention  personnel and facility leadership. <strong>(Category II)</strong> (Key Question 3.C.6)</li>
                          
                           <li>Consider limiting transfers to those  for which the receiving facility is able to maintain Contact Precautions;  otherwise, it may be prudent to postpone transfers until patients no longer  require Contact Precautions.  During  outbreaks, medically suitable individuals recovering from norovirus  gastroenteritis can be discharged to their place of residence.<strong>(Category II)</strong>  (Key Question 3.C.11) </li>
                            <li>Implement systems to designate patients  with symptomatic norovirus and to notify receiving healthcare facilities or  personnel prior to transfer of such patients within or between facilities.  <strong>(Category IC)</strong>  </li>
                            
                           <li>To prevent food-related outbreaks of  norovirus gastroenteritis in healthcare settings, food handlers must perform hand  hygiene prior to contact with or the preparation of food items and beverages. For more information visit the <a href="http://www.fda.gov/Food/FoodSafety/RetailFoodProtection/FoodCode/default.htm">FDA Food Code</a> website.  <strong>(Category IC)</strong>  (Key Question 1.C.3.a) </li>
                      
                        <li>Personnel who work with, prepare or  distribute food must be excluded from duty if they develop symptoms of acute  gastroenteritis.  Personnel should not  return to these activities until a minimum of 48 hours after the resolution of  symptoms or longer as required by local health regulations. For more information visit <a href="http://www.fda.gov/Food/FoodSafety/RetailFoodProtection/FoodCode/default.htm">FDA Food Code</a> website.  <strong>(Category IC)</strong>  (Key Question 1.C.3.b) </li>
                        
                           <li>Remove all shared or communal food  items for patients or staff from clinical areas for the duration of the  outbreak. <strong>(Category IB) </strong>(Key  Question 3.B.2) </li>
                           </ol>
                           
                           
                           <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                           
                           <h3 id="diag">Diagnostics                           </h3>
                           <ol start="16">
                           
                           <li value="16">Consider  the development and adoption of facility policies to enable rapid clinical and  virological confirmation of suspected cases of symptomatic norovirus infection  while implementing prompt control measures to reduce the magnitude of a  potential norovirus outbreak.<strong>(Category II)</strong>  (Key Question 1.C.1) </li>
                           
                             <li>In  the absence of clinical laboratory diagnostics or in the case of delay in  obtaining laboratory results, use Kaplan’s clinical and epidemiologic criteria  to identify a norovirus gastroenteritis outbreak (see Table 4 for Kaplan’s  criteria).  <strong>(Category IA)</strong>  (Key Question 2.A.1)  </li>
                          
                             <li>Further  research is needed to compare the Kaplan criteria with other early detection  criteria for outbreaks of norovirus gastroenteritis in healthcare settings, and  to assess whether additional clinical or epidemiologic criteria can be applied  to detect norovirus clusters or outbreaks in healthcare settings.  <strong>(No  recommendation/unresolved issue)</strong> (Key Question 2.A.1)  </li>
                          
                             <li>Consider  submitting stool specimens as early as possible during a suspected norovirus  gastroenteritis outbreak and ideally from individuals during the acute phase of  illness (within 2-3 days of onset).  It  is suggested that healthcare facilities consult with state or local public  health authorities regarding the types of and number of specimens to obtain for  testing.<strong>(Category II)</strong>  (Key Question  2.B)  </li>
                           
                             <li>Use  effective laboratory diagnostic protocols for testing of suspected cases of  viral gastroenteritis (e.g., refer to the Centers for Disease Control and  Prevention (CDC)'s most current <a href="https://www.cdc.gov/mmwr/pdf/rr/rr6003.pdf">recommendations for norovirus diagnostic  testing</a>  <strong>(Category IB)</strong>(Key Question 2.C) </li>
                           
                             <li>Routine  collecting and processing of environmental swabs during a norovirus outbreak is  not required.  When supported by  epidemiologic evidence, environmental sampling can be considered useful to confirm  specific sources of contamination during investigations. <strong>(Category II)</strong> </li>
                           
                             <li>Specimens  obtained from vomitus can be submitted for laboratory identification of  norovirus when fecal specimens are unavailable.   Testing of vomitus as compared to fecal specimens can be less sensitive  due to lower detectable viral concentrations. <strong>(Category II)</strong> </li>
                        </ol>
                             
                              <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                              
                             <h3 id="ppe">Personal Protective Equipment                             </h3>
                             <ol start="23">
                             
                             
                           <li value="23">If  norovirus infection is suspected, adherence to PPE use according to Contact and  Standard Precautions is recommended for individuals entering the patient care  area (i.e., gowns and gloves upon entry) to reduce the likelihood of exposure  to infectious vomitus or fecal material.    <strong>(Category IB)</strong>(Key Question 1.C.4)  </li>
                           
                             <li>Use  a surgical or procedure mask and eye protection or a full face shield if there  is an anticipated risk of splashes to the face during the care of patients,  particularly among those who are vomiting. <strong>(Category IB)</strong>(Key Question 3.C.2.a) </li>
                           
                             <li>More  research is needed to evaluate the utility of implementing Universal Gloving  (e.g., routine use of gloves for all patient care) during norovirus outbreaks. <strong>(No recommendation/unresolved issue) </strong></li>
                             </ol>
                             
                             
                              <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                              
                             <h3 id="ec">Environmental Cleaning</h3>
                             <ol start="26">
                             <li value="26">Perform  routine cleaning and disinfection of frequently touched environmental surfaces  and equipment in isolation and cohorted areas, as well as high-traffic clinical  areas.   Frequently touched surfaces include,  but are not limited to, commodes, toilets, faucets, hand/bedrailing,  telephones, door handles, computer equipment, and kitchen preparation surfaces. <strong>(Category IB)</strong>(Key Question 3.B.1) </li>
                          
                             <li>Clean  and disinfect shared equipment between patients using EPA-registered products  with label claims for use in healthcare.   Follow the manufacturer’s recommendations for application and contact  times.  The <a href="http://www.epa.gov/oppad001/chemregindex.htm">EPA lists products with  activity against norovirus</a> on their website.  <strong>(Category IC)</strong>  (Key Question 3.C.12.a)   </li>
                          
                             <li>Increase  the frequency of cleaning and disinfection of patient care areas and frequently  touched surfaces during outbreaks of norovirus gastroenteritis (e.g., increase ward/unit  level cleaning to twice daily to maintain cleanliness, with frequently touched  surfaces cleaned and disinfected three times daily using EPA-approved products  for healthcare settings).  <strong>(Category IB)</strong>(Key Question 3.C.12.b.1)     </li>
                           
                             <li>Clean  and disinfect surfaces starting from the areas with a lower likelihood of  norovirus contamination (e.g.,tray tables, counter tops) to areas with highly  contaminated surfaces (e.g., toilets, bathroom fixtures).  Change mop heads when a new bucket of  cleaning solution is prepared, or after cleaning large spills of emesis or  fecal material. <strong>(Category IB)</strong>(Key Question 3.C.12.b.2)</li>
                           
                             <li>Consider  discarding all disposable patient-care items and laundering unused linens from  patient rooms after patients on isolation for norovirus gastroenteritis are  discharged or transferred.   Facilities  can minimize waste by limiting the number of disposable items brought into rooms/areas  on Contact Precautions.<strong>(Category II)</strong>  (Key Question 3.C.12.c.1)</li>
                           
                             <li>No  additional provisions for using disposable patient service items such as  utensils or dishware are suggested for patients with symptoms of norovirus  infection. Silverware and dishware may undergo normal processing and cleaning  using standard procedures. <strong>(Category II)</strong>  (Key Question 3.C.12.c.2)</li>
                           
                             <li>Use  Standard Precautions for handling soiled patient-service items or linens,  including the use of appropriate PPE. <strong>(Category IB)</strong>(Key Question 3.C.12.c.3)</li>
                           
                             <li>Consider  avoiding the use of upholstered furniture and rugs or carpets in patient care  areas, as these objects are difficult to clean and disinfect completely.  If this option is not possible, immediately  clean soilage, such as emesis or fecal material, from upholstery, using a  manufacturer-approved cleaning agent or detergent.  Opt for seating in patient-care areas that  can withstand routine cleaning and disinfection. <strong>(Category II)</strong>  (Key Question 3.C.12.d.1) </li>
                          
                             <li>Consider  steam cleaning of upholstered furniture in patient rooms upon discharge.  Consult with manufacturer's recommendations  for cleaning and disinfection of these items.   Consider discarding items that cannot be appropriately  cleaned/disinfected. <strong>(Category II)</strong>  (Key Question 3.C.12.d.2)     </li>
                           
                             <li>During outbreaks, change privacy  curtains when they are visibly soiled and upon patient discharge or transfer. <strong>(Category IB)</strong>(Key Question 3.C.12.d.3)</li>
                           
                             <li>Handle soiled linens carefully,  without agitating them, to avoid dispersal of virus.  Use Standard Precautions, including the use  of appropriate PPE (e.g., gloves and gowns), to minimize the likelihood of cross-contamination. <strong>(Category IB)</strong> (Key Question 3.C.12.d.4)  </li>
                           
                             <li>Double bagging, incineration, or  modifications for laundering are not indicated for handling or processing soiled  linen. <strong>(Category II)</strong>  (Key Question 3.C.12.d.5)</li>
                           
                             <li>Clean surfaces and patient equipment  prior to the application of a disinfectant.    Follow the manufacturer’s recommendations for optimal disinfectant  dilution, application, and surface contact time with an EPA-approved product  with claims against norovirus.  <strong>(Category IC)</strong>  (Key Question 3.C.12.e.1)    </li>
                           
                             <li>More research is required to clarify  the effectiveness of cleaning and disinfecting agents against norovirus, either  through the use of surrogate viruses or the development of human norovirus  culture system.  <strong>(No recommendation/unresolved issue) </strong>(Key Question 3.C.12.e.2)</li>
                           
                             <li>More research is required to clarify  the effectiveness and reliability of fogging, UV irradiation, and ozone mists  to reduce norovirus environmental contamination.  <strong>(No  recommendation/unresolved issue) </strong>(Key Question 3.C.12.e.3)   </li>
                           
                             <li>Further research is required to  evaluate the utility of medications that might attenuate the duration and  severity of norovirus illness.  <strong>(No recommendation/unresolved issue )</strong> (Key  Question 3.D)</li>
                             
                             </ol>
                             
                             
                              <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                              
                             <h3 id="slp">Staff Leave and Policy</h3>
                             <ol start="42">
                             
                             <li value="42">Develop  and adhere to sick leave policies for healthcare personnel who have symptoms  consistent with norovirus infection.  <strong>(Category IB)</strong>(Key Question 3.C.3)
                             <ol>
                               <li>Exclude ill personnel from work for a minimum of 48 hours after the resolution  of symptoms. Once personnel return to work, the importance of performing  frequent hand hygiene should be reinforced, especially before and after each  patient contact. <strong>(Category IB)</strong>(Key  Question 3.C.3.a) </li>
                             </ol>
                              </li>
                          
                             <li>Establish  protocols for staff cohorting in the event of an outbreak of norovirus  gastroenteritis.  Ensure staff care for  one patient cohort on their ward and do not move between patient cohorts (e.g.,  patient cohorts may include symptomatic, asymptomatic exposed, or asymptomatic  unexposed patient groups).   <strong>(Category IB)</strong> (Key Question 3.C.5.a)   </li>
                          
                             <li>Exclude  non-essential staff, students, and volunteers from working in areas  experiencing outbreaks of norovirus gastroenteritis. <strong>(Category IB)</strong> (Key Question 3.C.5.c)</li>
                             </ol>
                             
                              <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                              
                             <h3 id="visit">Visitors</h3>
                             <ol start="45">
                             <li value="45">Establish  visitor policies for acute gastroenteritis (e.g., norovirus) outbreaks.   <strong>(Category IB)</strong>(Key Question 3.C.7.a)  </li>
                           
                             <li>Restrict  non-essential visitors from affected areas of the facility during outbreaks of  norovirus gastroenteritis. <strong>(Category IB)</strong>(Key Question 3.C.7.b)  
                             
                             <ol>
                               <li>For  those affected areas where it is necessary to have continued visitor privileges  during outbreaks, screen and exclude visitors with symptoms consistent with  norovirus infection and ensure that they comply with hand hygiene and Contact  Precautions. <strong>(Category IB)</strong>(Key  Question 3.C.7.b.1)</li>
                             </ol>
                             </li>
                             
                             </ol>
                             
                              <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                              
                             
                             <h3 id="edu">Education</h3>
                        <ol start="47">
                             <li value="47">Provide  education to staff, patients, and visitors, including recognition of norovirus  symptoms, preventing infection, and modes of transmission upon the recognition  and throughout the duration of a norovirus gastroenteritis outbreak. <strong>(Category IB)</strong>(Key Question 3.C.8.a)    </li>
                          
                             <li>Consider  providing educational sessions and making resources available on the prevention  and management of norovirus before outbreaks occur, as part of annual  trainings, and when sporadic cases are detected. <strong>(Category II)</strong>  (Key Question 3.C.8.b)</li>
                             
                        </ol>
                             
                             
                              <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                              
                             <h3 id="acf">Active  Case-Finding
                             
                             </h3>
                             <ol start="49">
                             <li value="49">Begin  active case-finding when a cluster of acute gastroenteritis cases is detected  in the healthcare facility.  Use a specified  case definition, and implement line lists to track both exposed and symptomatic  patients and staff.  Collect relevant  epidemiological, clinical, and demographic data as well as information on  patient location and outcomes. <strong>(Category&nbsp;IB)</strong> (Key Question 3.C.9.a) </li>
                             
                             </ol>
                             
                              <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                              
                             
                               <h3 id="cn">Communication and  Notification</h3>
                               <ol start="50">
                             <li value="50">Develop  written policies that specify the chains of communication needed to manage and  report outbreaks of norovirus gastroenteritis.   Key stakeholders such as clinical staff, environmental services,  laboratory administration, healthcare facility administration and public  affairs, as well as state or local public health authorities, should be  included in the framework. <strong>(Category&nbsp;IB)</strong> (Key Question 3.C.10)</li>
                           
                           <li>50a.Provide timely communication to  personnel and visitors when an outbreak of norovirus gastroenteritis is  suspected and outline what policies and provisions need to be followed to  prevent further transmission <strong>(Category IB) </strong>(Key Question 3.C.10.a)</li>
                           
                             <li> As with all outbreaks, notify appropriate  local and state health departments, as required by state and local public  health regulations, if an outbreak of norovirus gastroenteritis is suspected.    <strong>(Category IC)</strong>  (Key Question 3.C.9.b)</li>
                        </ol>
                        
                         <p class="topOPage"><a href="005_norovirus-summaryOrecs.html#">Top</a></p>
                        
                        <p>&nbsp;</p>
                     
                         
                        <div class="module rounders grey multiPage-horiz" id="tableOfContent">
<div class="inner">
<div class="t"></div>

<div class="hd">
<h4><span><a href="004_norovirus-exec-summary.html">Previous Page</a></span>
<span class="nextLink"><a href="006_norovirus-implement-audit.html">Next Page</a></span></h4>
</div>

<div class="bd"><span><a href="002_norovirus-toc.html">Table of Contents</a></span></div>
</div>

<div class="b">
<div></div>
</div>
</div> 
					 <!-- InstanceEndEditable -->
					<!-- /end .main-inner --></div>
					
				  <div id="linkPolicy">&nbsp;</div>
				<!-- /end #content-main--></div>
				
			<!-- /end #content-inner --></div>
			
			<!-- ########## RIGHT COLUMN STARTS HERE ########## -->
			<div id="content-secondary">
				<div class="pageOptions">
					<div class="pageOptions-inner">
						<!-- If you're seeing this, the text-sizer include is depricated and the server-side-include reference should be removed from all pages -->
						<ul id="services" class="services">
							<li class="print"><a href="javascript:window.print();" title="Print page.">Print page</a></li>
						</ul>
						<!-- InstanceBeginEditable name="local-options" -->
					
					<!-- InstanceEndEditable -->
						<!-- InstanceBeginEditable name="languages" -->
					 
				<!-- InstanceEndEditable -->
					</div>
				</div>
				
				
				<!-- InstanceBeginEditable name="gov-delivery" -->
			
			<!-- InstanceEndEditable -->
				<!-- InstanceBeginEditable name="contact-info" -->
			<div id="contact-info">
	<h5>Contact Us:</h5>
	<ul class="noBullet">
		<li class="mail">Centers for Disease Control and Prevention<br />
		1600 Clifton Rd<br />
		Atlanta, GA 30333</li>
		<li class="phone">800-CDC-INFO<br />
		(800-232-4636)<br />
		TTY: (888) 232-6348</li>
		<li><a href="../../cdc-info/requestform.html">Contact CDC&ndash;INFO</a></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				
			<!-- /end #content-secondary --></div>
			
		<!-- /end #content --></div>
		
		<div class="preFoot">
			<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><img src="../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><img src="../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><img src="../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><img src="../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><img src="../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><img src="../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><img src="../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><img src="../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
			<div class="pageOptions-horizontal">
				<ul class="services">
					<li class="print"><a href="javascript:window.print();">Print</a></li>

					<!-- InstanceBeginEditable name="local-options-horizontal" -->
				
				<!-- InstanceEndEditable -->
				</ul>
			</div>
			<div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
			<ul>
				<li class="last-reviewed">Page last reviewed: <span>May 4, 2011</span></li>
				<li class="last-updated">Page last updated: <span>May 4, 2011</span></li>
				 <li class="content-source">Content source: <a href="../../index.html">Centers for Disease Control and Prevention</a><br /> <a href="../../ncezid.1.html">National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)</a><br /> <a href="../../ncezid/dhqp/index.html">Division of Healthcare Quality Promotion (DHQP)</a></li>

			</ul>
		<!-- InstanceEndEditable -->
			</div>
		</div>
		
		<div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../index.html">Home</a></li>
			<li><a href="../../az/a.html">A-Z Index</a></li>
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
		
		<div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ol>
</div>

	<!-- /end #wrapper-inner --></div>
	
<!-- /end #wrapper --></div>

<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="HICPAC";

siteCatalyst.setLevel1("NCEZID"); 
siteCatalyst.setLevel2("DHQP"); 
siteCatalyst.setLevel3("Healthcare Infection Control Practices Advisory Committee"); 
siteCatalyst.setLevel4("Guidelines-HICPAC"); 
<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->



</body>
<!-- InstanceEnd --></html>
